Mochida Pharmaceutical Co Ltd (4534):企業の財務・戦略的SWOT分析

◆英語タイトル:Mochida Pharmaceutical Co Ltd (4534) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C5001
◆発行会社(調査会社):GlobalData
◆発行日:2018年9月
◆ページ数:36
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Mochida Pharmaceutical Co Ltd (4534) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Mochida Pharmaceutical Co Ltd (Mochida) is a pharmaceutical company that develops, manufactures and markets drugs and diagnostic regents. The company’s drugs are used for the treatment of arteriosclerosis obliterans, hyperlipidemia, hypertension, angina pectoris, endometriosis, mycosis, thrombosis, acute circulatory failure, acute pancreatitis, acute myocardial infarction, depression and depressive symptoms, chronic pain, diabetes, neutropenia and others. Its products under development are intended for the treatment of ulcerative colitis, rheumatoid arthritis, adenomyosis, osteoporosis, articular cartilage lesion, chronic constipation and others. The company also offers contract manufacturing of pharmaceuticals. Mochida is headquartered in Tokyo, Japan.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Section 1 – About the Company 5
Mochida Pharmaceutical Co Ltd – Key Facts 5
Mochida Pharmaceutical Co Ltd – Key Employees 6
Mochida Pharmaceutical Co Ltd – Key Employee Biographies 7
Mochida Pharmaceutical Co Ltd – Major Products and Services 8
Mochida Pharmaceutical Co Ltd – History 9
Mochida Pharmaceutical Co Ltd – Company Statement 10
Mochida Pharmaceutical Co Ltd – Locations And Subsidiaries 12
Head Office 12
Other Locations & Subsidiaries 12
Section 2 – Company Analysis 13
Company Overview 13
Mochida Pharmaceutical Co Ltd – Business Description 14
Business Segment: Pharmaceutical 14
Overview 14
Performance 14
Business Segment: Skin Care 14
Overview 14
Performance 15
R&D Overview 15
Mochida Pharmaceutical Co Ltd – Corporate Strategy 16
Mochida Pharmaceutical Co Ltd – SWOT Analysis 17
SWOT Analysis – Overview 17
Mochida Pharmaceutical Co Ltd – Strengths 17
Mochida Pharmaceutical Co Ltd – Weaknesses 18
Mochida Pharmaceutical Co Ltd – Opportunities 19
Mochida Pharmaceutical Co Ltd – Threats 20
Mochida Pharmaceutical Co Ltd – Key Competitors 21
Section 3 – Company Financial Ratios 22
Financial Ratios – Capital Market Ratios 22
Financial Ratios – Annual Ratios 23
Performance Chart 26
Financial Performance 26
Financial Ratios – Interim Ratios 27
Financial Ratios – Ratio Charts 28
Section 4 – Company’s Lifesciences Financial Deals and Alliances 29
Mochida Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 29
Mochida Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 30
Mochida Pharmaceutical Co Ltd, Recent Deals Summary 31
Section 5 – Appendix 32
Methodology 32
Ratio Definitions 32
About GlobalData 36
Contact Us 36
Disclaimer 36

List of Tables
Mochida Pharmaceutical Co Ltd, Key Facts 5
Mochida Pharmaceutical Co Ltd, Key Employees 6
Mochida Pharmaceutical Co Ltd, Key Employee Biographies 7
Mochida Pharmaceutical Co Ltd, Major Products and Services 8
Mochida Pharmaceutical Co Ltd, History 9
Mochida Pharmaceutical Co Ltd, Other Locations 12
Mochida Pharmaceutical Co Ltd, Subsidiaries 12
Mochida Pharmaceutical Co Ltd, Key Competitors 21
Mochida Pharmaceutical Co Ltd, Ratios based on current share price 22
Mochida Pharmaceutical Co Ltd, Annual Ratios 23
Mochida Pharmaceutical Co Ltd, Annual Ratios (Cont...1) 24
Mochida Pharmaceutical Co Ltd, Annual Ratios (Cont...2) 25
Mochida Pharmaceutical Co Ltd, Interim Ratios 27
Mochida Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 29
Mochida Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 30
Mochida Pharmaceutical Co Ltd, Recent Deals Summary 31
Currency Codes 32
Capital Market Ratios 32
Equity Ratios 33
Profitability Ratios 33
Cost Ratios 34
Liquidity Ratios 34
Leverage Ratios 35
Efficiency Ratios 35

List of Figures
Mochida Pharmaceutical Co Ltd, Performance Chart (2014 - 2018) 26
Mochida Pharmaceutical Co Ltd, Ratio Charts 28
Mochida Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 29
Mochida Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 30

★海外企業調査レポート[Mochida Pharmaceutical Co Ltd (4534):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • IVRCL Ltd:企業の戦略・SWOT・財務情報
    IVRCL Ltd - Strategy, SWOT and Corporate Finance Report Summary IVRCL Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • HD Supply Inc:企業の戦略的SWOT分析
    HD Supply Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Compagnie Ivoirienne d’Electricite (CIEC):企業の財務・戦略的SWOT分析
    Summary Compagnie Ivoirienne d'Electricite (CIE), a subsidiary of Eranove, is a power company that provides power generation, transmission, and distribution services. The company offers exporting, importing and marketing of electricity. It provides operation and management of hydroelectric and therm …
  • IndigoVision Group plc (IND):企業の財務・戦略的SWOT分析
    Summary IndigoVision Group plc (IndigoVision) is a developer, manufacturer and distributor of end-to-end IP security management systems. The company’s products include management software, cameras and encoders, specialized cameras, body worn video, integration and recorders. Its camera and encoder’s …
  • Medical Prognosis Institute AS (MPI):医療機器:M&Aディール及び事業提携情報
    Summary Medical Prognosis Institute A/S (MPI) is a precision medicine provider that offers cancer treatment solutions. The company offers drug response prediction platforms that provide tools for rationalized drug development and personalized medicine. It offers lead compound selection, drug rescue …
  • Harman International Industries, Incorporated:企業のM&A・事業提携・投資動向
    Harman International Industries, Incorporated - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Harman International Industries, Incorporated Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, …
  • Huron Consulting Group Inc
    Huron Consulting Group Inc - Strategy, SWOT and Corporate Finance Report Summary Huron Consulting Group Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Sunwin Stevia International Inc (SUWN):企業の財務・戦略的SWOT分析
    Sunwin Stevia International Inc (SUWN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • iMDsoft Inc:企業の戦略的SWOT分析
    iMDsoft Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • SOLX Inc-医療機器分野:企業M&A・提携分析
    Summary Solx Inc (SOLX) is a medical device company that develops therapeutic products. The company provides glaucoma surgery devices and treatments for glaucoma therapy. Its SOLX gold shunt is a minimally invasive device, which is used in surgical treatment of glaucoma. SOLX’s product is a gold imp …
  • Infinity Pharmaceuticals Inc (INFI)-製薬・医療分野:企業M&A・提携分析
    Summary Infinity Pharmaceuticals Inc (Infinity Pharmaceuticals) is a biopharmaceutical company, which discovers and develops medicines to people suffering with difficult-to-treat diseases. It focuses on small molecule drugs designed to address diseases in the areas of cancer and inflammation. The co …
  • Cerevance Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Cerevance Inc (Cerevance) is a pharmaceutical company that strives to develop medicines for the treatment of neurological and psychiatric diseases. It is also developing preclinical and clinical programs for Parkinson's disease, L-Dopa induced dyskinesia, cognitive impairment, neuroinflammat …
  • KPMG International Coop:企業の戦略的SWOT分析
    KPMG International Coop - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Food Empire Holdings Limited:企業の戦略・SWOT・財務情報
    Food Empire Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Food Empire Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Robert Half International Inc. (RHI):企業の財務・戦略的SWOT分析
    Robert Half International Inc. (RHI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • BOE Technology Group Co Ltd:企業の戦略・SWOT・財務情報
    BOE Technology Group Co Ltd - Strategy, SWOT and Corporate Finance Report Summary BOE Technology Group Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • AK Steel Holding Corp:企業の戦略・SWOT・財務情報
    AK Steel Holding Corp - Strategy, SWOT and Corporate Finance Report Summary AK Steel Holding Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Agappe Diagnostics Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Agappe Diagnostics Ltd (Agappe) is an in vitro diagnostic company that manufactures clinical chemistry and immuno turbidimetry products. The company’s products categories include biochemistry, immunochemistry, serology, coagulation, hematology, system reagents, controls and calibrators; poin …
  • Resona Holdings, Inc.:企業の戦略・SWOT・財務分析
    Resona Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary Resona Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Trivitron Healthcare Pvt Ltd:企業のM&A・事業提携・投資動向
    Trivitron Healthcare Pvt Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Trivitron Healthcare Pvt Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆